SNM practice guideline for parathyroid scintigraphy 4.0

Journal of Nuclear Medicine Technology

Volumn 40, Issue 2, 2012, Pages 111-118

  Greenspan, Bennett S ^a   Dillehay, Gary ^b   Intenzo, Charles ^c   Lavely, William C ^d   O'Doherty, Michael ^e   Palestro, Christopher J ^f   Scheve, William ^g   Stabin, Michael G ^h   Sylvestros, Delynn ^g   Tulchinsky, Mark ⁱ  

^a Northwestern University ^*

^b NORTHWESTERN UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d St Thomas' Hospital   (United States)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f Northwell Health   (United States)

^g BARNES JEWISH HOSPITAL   (United States)

^h VANDERBILT UNIVERSITY   (United States)

ⁱ PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; TETROFOSMIN TC 99M;

ARTICLE; HUMAN; INFECTION CONTROL; MEDICAL SOCIETY; NUCLEAR MEDICINE TECHNICIAN; PARATHYROID SCINTISCANNING; PATIENT EDUCATION; PRACTICE GUIDELINE; RADIATION DOSE; RADIATION EXPOSURE; RADIATION SAFETY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIETY OF NUCLEAR MEDICINE; THERAPEUTIC ERROR;

DOCUMENTATION; HEALTH PERSONNEL; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFECTION CONTROL; NUCLEAR MEDICINE; PARATHYROID GLANDS; PATIENT EDUCATION AS TOPIC; QUALITY CONTROL; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RESEARCH DESIGN; SAFETY; SOCIETIES, SCIENTIFIC;

EID: 84865970281     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.112.105122     Document Type: Article

References (31)

1. 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery. 1997;122:1107-1114.
2. Johnston LB, Carroll MJ, Britton KE, et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab. 1996;81:346-352.
3. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med. 2005;35:266-276.
4. O'Doherty MJ, Kettle AG, Wells P, et al. Parathyroid imaging with technetium-99m sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33:313-318.
5. Sfakianakis GN, Irvin GL III, Foss J, et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med. 1996;37:798-804.
6. Akram K, Parker JA, Donohoe K, Kolodny G. Role of single photon emission computed tomography/computed tomography in localization of ectopic parathyroid adenoma: a pictorial case series and review of the current literature. Clin Nucl Med. 2009;34:500-502.
7. 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidism. Ann Surg. 2009;250:868-871.
8. Hindié E, Ugur O, Fuster D, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201-1216.
9. Harris L, Yoo J, Driedger A, et al. Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck. 2008;30:509-517.
10. Hindié E, Melliere D, Simon D, et al. Primary hyperparathyroidism: is technetium-99m-sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab. 1995;80:302-307.
11. Perez-Monte JE, Brown ML, Shah AN, et al. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology. 1996;201:85-91.
12. 99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperthyroidism. J Nucl Med. 2008;49:2012-2017.
13. Chen CC, Skarulis MC, Fraker DL, et al. Technetium-99m sestamibi imaging before reoperation for primary hyperparathyroidism. J Nucl Med. 1995;36:2186-2191.
14. Majors JD, Burke GJ, Mansberger AR, et al. Technetium Tc-99m sestamibi scan for localizing abnormal parathyroid glands after previous neck operations: preliminary experience in reoperative cases. South Med J. 1995;88:327-330.
15. Weber CJ, Vansant J, Alazraki N, et al. Value of technetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery. Surgery. 1993;114:1011-1018.
16. Doppman JL, Skarulis MC, Chen CC, et al. Parathyroid adenomas in the aortopulmonary window. Radiology. 1996;201:456-462.
17. 201Tl, MRI and US. Eur J Nucl Med. 2001;28:1817-1827.
18. 99mTcsestamibi for double-phase parathyroid scintigraphy? Eur J Nucl Med Mol Imaging. 2003;30:193-196.
19. Thomas DL, Bartel T, Menda Y, Howe J, Graham MM, Juweid ME. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy. Clin Nucl Med. 2009;34:651-655.
20. Lindqvist V, Jacobsson H, Chandanos E, Backdahl M, Kjellman M, Wallin G. Preoperative 99Tc(m)-sestamibi scintigraphy with SPECT localizes most pathologic parathyroid glands. Langenbecks Arch Surg. 2009;394:811-815.
21. 99mTc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084-1089.
22. Nichols KJ, Tomas MB, Tronco GG, et al. Optimizing the accuracy of preoperative parathyroid lesion localization. Radiology. 2008;248:221-232.
23. Wimmer G, Profanter C, Kovacs P, et al. CT-MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism. Langenbecks Arch Surg. 2010; 395:73-80.
24. Fuster D, Torregrosa JV, Setoain X, et al. Localising imaging in secondary hyperparathyroidism. Minerva Endocrinol. 2008;33:203-212.
25. 99mTc sestamibi SPECT and SPECT/CT. Radiographics. 2008;28:1461-1476.
26. Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for SPECT/CT imaging 1.0. J Nucl Med. 2006;47:1227-1234.
27. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals: a third addendum to ICRP publication 53, ICRP publication 106. Approved by the Commission in October 2007. Ann ICRP. 2008;38:1-197.
28. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals: addendum 2 to ICRP publication 53. Ann ICRP. 1998;28:1-126.
29. International Commission on Radiological Protection. ICRP publication 53: radiation dose to patients from radiopharmaceuticals. Ann ICRP. 1988; 18:1-4.
30. Russell JR, Stabin MG, Sparks RB, Watson E. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. Health Phys. 1997;73:756-769.
31. Watson EE. Radiation absorbed dose to the human fetal thyroid. In: Fifth International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, Tennessee: Oak Ridge Associated Universities; 1992:179-187.